Skip to main content
. 2014 Apr 13;15(2):151–157. doi: 10.1007/s10238-014-0284-7

Table 4.

Distribution of 241Thr/Thr, 241Thr/Met, and 241Met/Met genotypes and frequencies of the Thr and Met alleles in patients with triple-negative breast cancer and controls

XRCC3 Thr241Met TNBC patients (n = 70) Controls (n = 70) OR (95 % CI)a p b
Number (%) Number (%)
241Thr/Thr 19 27 15 21 1.00 Ref
241Thr/Met 35 49 35 50 0.78 (0.34–1.79) 0.718
241Met/Met 16 23 20 29 0.63 (0.24–1.62) 0.475
241Thr 73 52 65 46 1.00 Ref
241Met 67 48 75 54 0.79 (0.49–1.27) 0.402

aCrude odds ratio (OR), 95 % CI = confidence interval at 95 %

bChi square